Watch Ticker

Outlook Therapeutics, Inc. Common Stock

Go to Outlook Therapeutics, Inc. Common Stock Website

$2.02

0.01 (0.50%)

Live

Previous Close

$2.01

Day Range

$1.97 - $2.05

Previous Day Range

$1.9 - $2.05

Market Cap

$82.7 million USD

Day Vol.

671620

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an oph...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Fn Media Group - Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

The retinal and fundus camera market is experiencing growth driven by the evolving landscape of imaging technologies, particularly in diagnosing age-related macular degeneration (AMD). The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth, with AI algorithms demonstrating high accuracy in detecting diseases like diabetic retinopathy (DR).

Related tickers: AVAI, OTLK, EYEN, BLCO, BMEA.

Read Full Article

Globe Newswire - Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering

Outlook Therapeutics, a biopharmaceutical company, announced the pricing of a $13.0 million public offering of common stock and accompanying warrants. The company plans to use the net proceeds for working capital and general corporate purposes.

Related tickers: OTLK.

Read Full Article

Trending Tickers

Please sign in to view